For the Inventor, By the Inventor

Enter assignee name

Niigata University

USPTO Granted Patents = 73

% Expired Patents = 41.1

EPO Patents = 39

Forward Citations = 250

Loading Chart...

Loading Chart...

164 inventors (with patents filed for the assignee):

Akihiko Saito (8 out of 8 patents)

Norio Tsubokawa (5 out of 6 patents)

Yoshiaki Hirayama (5 out of 10 patents)

4. Kenji Toda (5 out of 9 patents)

5. Mineo Sato (5 out of 6 patents)

6. Kazuyoshi Uematsu (5 out of 5 patents)

7. Shinya Ogasawara (5 out of 6 patents)

8. Eisaku Kondo (4 out of 4 patents)

9. Tsutomu Sato (3 out of 6 patents)

10. Takayoshi Shimohata (3 out of 3 patents)

11. Shujiro Okuda (3 out of 3 patents)

12. Hiroshi Izutsu (3 out of 3 patents)

13. Keisuke Kodama (3 out of 3 patents)

14. Nobuyuki Gokon (3 out of 3 patents)

15. Tatsuya Kodama (3 out of 4 patents)

Core Competencies:

Antisense Oligonucleotide

Anti-Inflammatory Macrophage

Cancer Thermotherapy

Kidney Injury Prevention

Nuclear Magnetic Resonance

Silicon Wafer Manufacturing

Pharmaceutical Composition

Peptide Development

Aquaporin Modulators

Magnetic Field Devices

Image Processing

Hydrogen Production

73 patents: Sort by Forward Citations

1. 12742791 - Method, analysis system, analyzer, and computer program for analyzing cause of prolonging coagulation time (2026-09-22),

2. 12678511 - PEPTIDE AND USE THEREOF (2026-07-14),

3. 12584133 - ANTISENSE NUCLEIC ACID AND USE THEREOF (2026-03-24),

4. 12482587 - Magnetic field generating device (2025-11-25),

5. 12387339 - Data generation apparatus, data generation method, and program (2025-08-12),

6. 12350293 - Induction method for macrophage, anti-inflammatory macrophage-inducing agent, and pharmaceutical composition (2025-07-08),

7. 12291710 - Antisense oligonucleotide targeting ATN1 mRNA or pre-mRNA (2025-05-06),

8. 12239621 - Prevention of kidney injury induced by hemolytic reaction (2025-03-04),

9. 11869190 - System, program, and method for determining hypermutated tumor (2024-01-09),

10. 11858984 - Anti-S100A8/A9 antibody and use thereof (2024-01-02),

11. 11813244 - Agent for eliminating senescent cells (2023-11-14),

12. 11542647 - Method for manufacturing sheet for use in tongue plaque cleaner (2023-01-03),

13. 11541580 - Method for preparing compact of resin compound having anisotropy (2023-01-03),

14. 11447525 - Peptide and use therefor (2022-09-20),

15. 11414655 - Efficient method for producing ambrein (2022-08-16),

Company Overview

Niigata University, located in Niigata, Japan, is a prominent institution specializing in advanced research and development in nucleic acid technologies. The university focuses on innovative applications such as antisense oligonucleotides, anti-inflammatory macrophages, and cancer thermotherapy. Additionally, it explores critical areas like kidney injury prevention, nuclear magnetic resonance, and peptide development, contributing significantly to pharmaceutical compositions and silicon wafer manufacturing. Its research initiatives aim to address pressing health challenges and enhance technological capabilities.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

73 Patents

#3 in Niigata

#1,380 in Japan

#10,273 in the World

Niigata University

Forward Citations = 250

164 inventors:

Akihiko Saito (8 out of 8 patents)

Norio Tsubokawa (5 out of 6 patents)

Yoshiaki Hirayama (5 out of 10 patents)

4. Kenji Toda (5 out of 9 patents)

5. Mineo Sato (5 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Niigata University. Retrieved from https://idiyas.com/company/niigata-university

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…